{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:30:57Z","timestamp":1762176657444,"version":"3.37.3"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T00:00:00Z","timestamp":1368662400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0064217","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T21:08:24Z","timestamp":1368738504000},"page":"e64217","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Movement Disorders in Elderly Users of Risperidone and First Generation Antipsychotic Agents: A Canadian Population-Based Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Irina","family":"Vasilyeva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Biscontri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray W.","family":"Enns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen J.","family":"Metge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Alessi-Severini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,5,16]]},"reference":[{"key":"ref1","unstructured":"Sitar DS (2008) Principles of medical pharmacology. In: Kalant H, Grant DM, Mitchell J, editors. Geriatric Clinical Pharmacology (7th Edition). Elsevier, ON, Canada,832840."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/bmj.39503.424653.80","article-title":"Prescribing to older people","volume":"336","author":"JC Milton","year":"2008","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11606-010-1629-x","article-title":"Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials","volume":"26(7)","author":"DM Zulman","year":"2011","journal-title":"J Gen Intern Med"},{"key":"ref4","first-page":"CD003476","article-title":"The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease","volume":"(1)","author":"C Ballard","year":"2006","journal-title":"Cochrane Databas Syst Rev 2006 Jan 25"},{"key":"ref5","unstructured":"McDonagh MS, Peterson K, Carson S, Fu R, Thakurta S (2010) Drug class review\u2013Atypical Antipsychotic Drugs - Final update report\u2013July 2010 - Oregon Health & Science University. Available: http:\/\/www.ohsu.edu\/xd\/research\/index.cfm<\/ext-link> Accessed November 16, 2012."},{"key":"ref6","first-page":"35","article-title":"Atypical antipsychotics for the treatment of behavioural and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality","volume":"10(1)","author":"C Ballard","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/YCO.0b013e32834a3f47","article-title":"Recent advances in pharmacological treatment of psychosis in late life","volume":"24","author":"W Chan","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"ref8","first-page":"e109","article-title":"Off-label use of antipsychotic medications in Medicaid","volume":"18(3)","author":"DL Leslie","year":"2012","journal-title":"Am J Manag Care"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/11319120-000000000-00000","article-title":"Cerebrovascular accidents in elderly people treated with antipsychotic drugs: a systematic review","volume":"33(4)","author":"E Sacchetti","year":"2010","journal-title":"Drug Saf"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa052827","article-title":"Risk of death in elderly users of conventional vs. atypical antipsychotic medications","volume":"353(22)","author":"PS Wang","year":"2005","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","article-title":"Antipsychotic drug use and mortality in older adults with dementia","volume":"146(11)","author":"SS Gill","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref12","first-page":"627","article-title":"Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients CMAJ","volume":"176(5)","author":"S Schneeweiss","year":"2007"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/j.1532-5415.2008.01839.x","article-title":"Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications","volume":"56(9)","author":"S Setoguchi","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.4088\/JCP.08m04597yel","article-title":"All-cause mortality associated with atypical and conventional antipsychotics among nursing home residents with dementia: a retrospective cohort study","volume":"70(10)","author":"R Liperoti","year":"2009","journal-title":"J Clin Psychiatry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/appi.ajp.2007.06101710","article-title":"Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications","volume":"164(10)","author":"HC Kales","year":"2007","journal-title":"Am J Psychiatry"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/pds.1334","article-title":"All-cause mortality associated with atypical and typical antipsychotics in demented outpatients","volume":"6(5)","author":"G Trifiro","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/01.jcp.0000203598.43314.34","article-title":"Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients","volume":"26(2)","author":"MJ Barnett","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archinte.168.10.1090","article-title":"Antipsychotic therapy and short-term serious events in older adults with dementia","volume":"168(10)","author":"PA Rochon","year":"2008","journal-title":"Arch Intern Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360(3)","author":"WA Ray","year":"2009","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/0269881108093583","article-title":"Risk of cerebrovascular events in elderly users of antipsychotics","volume":"23(8)","author":"BC Kleijer","year":"2009","journal-title":"J Psychopharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4088\/JCP.09m05817yel","article-title":"Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study","volume":"71(6)","author":"S Mehta","year":"2010","journal-title":"J Clin Psychiatr"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12603-012-0057-5","article-title":"Are typical antipsychotics safer than typical antipsychotics for treating behavioural and psychological symptoms of dementia?","volume":"16(6)","author":"A Gurevich","year":"2012","journal-title":"J Nutr Health and Aging"},{"key":"ref23","unstructured":"Pratt N, Roughead EE, Salter A, Paul R (2012) Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review. BMC Medical Research Methodology 12: 72. Available: http:\/\/www.biomedcentral.com\/1471-2288\/12\/72<\/ext-link>.Accessed November 16, 2012."},{"key":"ref24","unstructured":"Health Canada. Important drug safety information: RISPERDAL* (risperidone) and cerebrovascular adverse events in placebo-controlled dementia trials - Janssen-Ortho inc. Available: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/medeff\/advisories-avis\/prof\/_2002\/risperdal_hpc-cps-eng.php<\/ext-link>. Accessed November 16, 2012."},{"key":"ref25","unstructured":"Health Canada. ZYPREXA* (olanzapine) and cerebrovascular adverse events in placebo-controlled elderly dementia trials. Available: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/medeff\/advisories-avis\/prof\/_2004\/zyprexa_hpc-cps-eng.php<\/ext-link>. Accessed November 16, 2012."},{"key":"ref26","unstructured":"Health Canada. Increased mortality associated with the use of atypical antipsychotic drugs in elderly patients with dementia. Available: http:\/\/www.hc-sc.gc.ca\/dhp-mps\/medeff\/advisories-avis\/prof\/_2005\/atyp-antipsycho_hpc-cps-eng.php<\/ext-link>. Accessed November 16, 2012."},{"key":"ref27","unstructured":"The Food and Drug Administration (2008) FDA requests boxed warnings on older class of antipsychotic drugs. Available: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2008\/ucm116912.htm<\/ext-link>. Accessed November 16, 2012"},{"key":"ref28","unstructured":"Drug safety update. Antipsychotics: use in elderly people with dementia. Available: http:\/\/www.mhra.gov.uk\/Safetyinformation\/DrugSafetyUpdate\/CON088116<\/ext-link>. Accessed January 4, 2013."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1503\/cmaj.071540","article-title":"Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis","volume":"179(5)","author":"E Valiyeva","year":"2008","journal-title":"CMAJ"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2009.01425.x","article-title":"Antipsychotic prescribing trends: a review of pharmacoepidemiological studies","volume":"121","author":"H Verdoux","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/JCP.0b013e31827934a4","article-title":"Adverse Events in Elderly Users of Antipsychotic Pharmacotherapy in the Province of Manitoba: a Retrospective Cohort Study","volume":"33(1)","author":"I Vasilyeva","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.111.101485","article-title":"Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs","volume":"200","author":"MJ Peluso","year":"2012","journal-title":"BJP"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.21854","article-title":"Failure of recognition of drug-induced parkinsonism in the elderly","volume":"23(3)","author":"CD Esper","year":"2008","journal-title":"Movement Disorders"},{"key":"ref34","first-page":"53","article-title":"Ambulatory care groups: a categorization of diagnoses for research and management","volume":"26(1)","author":"B Starfield","year":"1991","journal-title":"Health Serv Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00005650-199105000-00006","article-title":"Development and application of a population-oriented measure of ambulatory care case-mix","volume":"29(5)","author":"JP Weiner","year":"1991","journal-title":"Med Care"},{"key":"ref36","unstructured":"Reid RJ, MacWilliam L, Roos N, Bogdanovic B, Black B (1999) Measuring morbidity in populations: performance of the Johns Hopkins adjusted clinical group (ACG) case-mix adjustment system in Manitoba. Manitoba Centre for Health Policy. Available: http:\/\/mchp-appserv.cpe.umanitoba.ca\/reference\/acg.pdf<\/ext-link> Accessed November 16, 2012."},{"key":"ref37","unstructured":"The Manitoba Centre for Health Policy. Concept: Adjusted clinical group (ACG) - overview. Available: http:\/\/umanitoba.ca\/faculties\/medicine\/units\/community_health_sciences\/departmental_units\/mchp\/resources\/concept_dictionary.html<\/ext-link>. Accessed January 4, 2013."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1176\/ps.2008.59.5.547","article-title":"Utilization and costs of antipsychotic agents: a Canadian population-based study: 1996\u20132006","volume":"(5)","author":"S Alessi-Severini","year":"2008","journal-title":"Psychiatr Serv 59"},{"key":"ref39","unstructured":"The Canadian Institute for Health Information (2009) Antipsychotic use in seniors: an analysis focusing on drug claims, 2001 to 2007. Available: https:\/\/secure.cihi.ca\/estore\/productFamily.htm?pf=PFC1350&lang=en&media=0<\/ext-link>.Accessed November 16, 2012."},{"key":"ref40","unstructured":"Martinez C, Jones RW, Rietbrock S (2013) Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open 3:e002080. Available: http:\/\/bmjopen.bmj.com\/content\/3\/1\/e002080<\/ext-link>.Accessed January 10, 2013."},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Schulze J, van den Bussche H, Glaeske G, Kaduszkiewicz H, Wiese B, et al<\/etal>.. (2013) Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances. Eur Neuropsychopharmacol Mar 13 doi: 10.1016\/j.euroneuro.2013.02.001<\/ext-link>.","DOI":"10.1016\/j.euroneuro.2013.02.001"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2010.200","article-title":"Trends in antipsychotic use in dementia 1999\u20132007","volume":"68(2)","author":"HC Kales","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9343(99)80104-1","article-title":"Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study","volume":"99(1)","author":"J Avorn","year":"1995","journal-title":"Am J Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/archinte.165.16.1882","article-title":"Atypical antipsychotics and parkinsonism","volume":"165(16)","author":"PA Rochon","year":"2005","journal-title":"Arch Intern Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1532-5415.2005.53418.x","article-title":"Antipsychotic medications and drug-induced movement disorders other than parkinsonism: A population-based cohort study in older adults","volume":"53(8)","author":"PE Lee","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/pgmj.2008.073312","article-title":"Drug induced parkinsonism: a common cause of parkinsonism in older people","volume":"85(1004)","author":"B Thanvi","year":"2009","journal-title":"Postgrad Med J"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: Mechanism of action","volume":"47(1)","author":"P Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"ref48","unstructured":"Stahl SM (2003) Describing an atypical antipsychotic: Receptor binding and its role in pathophysiology. Primary care companion J Clin Psychiatry (suppl 3): 9\u201313."},{"key":"ref49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199503000-00003","article-title":"A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors","volume":"10(1)","author":"H He","year":"1995","journal-title":"Int Clin Psychopharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0064217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T20:07:53Z","timestamp":1688242073000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0064217"}},"subtitle":[],"editor":[{"given":"Devendra","family":"Amre","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,5,16]]},"references-count":49,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,5,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0064217","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2013,5,16]]}}}